TuHURA Biosciences (HURA) Depreciation and Depletion (2021 - 2026)
TuHURA Biosciences' (HURA) quarterly Depreciation and Depletion came in at $23000.0 in Q1 2026, up 64.29% year-on-year from $14000.0 in Q1 2025, and up 4.55% quarter-over-quarter from $22000.0 in Q4 2025.
TuHURA Biosciences (HURA) Depreciation and Depletion (2021 - 2026) Analysis & Trends
TuHURA Biosciences' Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $23000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 64.29% year-over-year to $23000.0 in Q1 2026; TTM through Mar 2026 was $80000.0, a 50.31% decrease from a year earlier, with the FY2025 full-year figure at $71000.0, down 39.32% from the prior year.
- Depreciation and Depletion improved to $23000.0 in Q1 2026 per HURA's latest filing, from $22000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $70000.0 in Q2 2024 and bottomed at $14000.0 in Q1 2025.
- The 5-year median for Depreciation and Depletion is $15000.0 (2022), against an average of $24066.7.
- Across the five-year window, Depreciation and Depletion soared 366.67% in 2024 and slumped 80.0% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $15000.0 in 2022, then soared by 100.0% to $30000.0 in 2023, then rose by 30.0% to $39000.0 in 2024, then plunged by 43.59% to $22000.0 in 2025, then rose by 4.55% to $23000.0 in 2026.
- Per Business Quant, the three latest HURA Depreciation and Depletion figures stand at $23000.0 (Q1 2026), $22000.0 (Q4 2025), and $21000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Sep 30, 2023 | 15,000.00 |